The largest database of trusted experimental protocols

Winnonlin version 6

Manufactured by Certara
Sourced in United States

WinNonlin version 6.4 is a software application developed by Certara for pharmacokinetic and pharmacodynamic analysis. It provides tools for data visualization, model fitting, and simulation.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using winnonlin version 6

1

Pharmacokinetic Analysis of Drug Candidates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard non-compartmental methods using WinNonlin version 6.4 (Certara United States of America Inc,.) were used to analyze plasma PK data, including peak plasma concentration (Cmax), time to peak plasma concentration (Tmax), area under the plasma concentration–time curve from time 0 to the last timepoint with a quantifiable concentration (AUC0-t), AUC from time 0 to infinity (AUC0-∞), t1/2, clearance (CL/F), and apparent volume of distribution (Vz/F).
Statistical analysis was performed using SAS software, version 9.4 (SAS Institute Inc., United States). Continuous variables were reported as number, mean with standard deviation, median, maximum, and minimum. Categorical variables, were reported as frequency and percentage. Dose proportionality was explored using a regression power model, relating log-transformed Cmax and AUC and log-transformed dose.
+ Open protocol
+ Expand
2

Noncompartmental Pharmacokinetic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PK parameters were estimated with noncompartmental methods using WinNonlin version 6.4 (Certara, Princeton, NJ). The peak plasma concentration (Cmax) and time to reach the peak plasma concentration (Tmax) were calculated from the actual plasma concentration data. The area under the plasma concentration-time curve from zero to the last measurable concentration (AUC0-t) was calculated via the linear trapezoidal rule. The AUC0-∞ was calculated using the following formula: AUC0-∞ = AUC0-t + Ct/ke, where Ct is the last plasma concentration measured. The terminal elimination half-life (t1/2) was calculated as 0.693/ke. The oral clearance (CL/F) and volume of distribution (Vz/F) were defined as Dose/AUC0-∞ and Dose/(ke·AUC0-∞), respectively.
+ Open protocol
+ Expand
3

Pharmacokinetic Parameter Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-compartmental analysis with WinNonlin version 6.4 (Certara, Princeton, NJ, USA) was used to compute the peak drug concentration (C max ), the time to C max (T max ) and the area under the curve for 0-8 h (AUC 0-8 ), the AUC for 0 to infinity (AUC 0-' ) and the half-life (t 1/2 ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!